FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Haim Tsubery

Research Profile

Chemicals & Drugs

Phenomena

Hydrolysis

Procedures

Living Beings

Anatomy

Cells, Cultured

Co-author Network

Publications

TOP 3
Yoram Shechter; Marina Mironchik; Sara Rubinraut; Haim Tsubery; K Sasson; Y Marcus; Mati Fridkin
Reversible pegylation of insulin facilitates its prolonged action in vivo.
Haim Tsubery; Milan Mrksich
Biochemical assays of immobilized oligonucleotides with mass spectrometry.
Haim Tsubery; Hertzig Yaakov; Sofia Cohen; Tal Giterman; Ariella Matityahou; Mati Fridkin; Itzhak Ofek
Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Haim Tsubery (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Yoram Shechter; Marina Mironchik; Sara Rubinraut; Haim Tsubery; K Sasson; Y Marcus; Mati Fridkin
Reversible pegylation of insulin facilitates its prolonged action in vivo.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;70(1):19-28.
2008: Haim Tsubery; Milan Mrksich
Biochemical assays of immobilized oligonucleotides with mass spectrometry.
Langmuir : the ACS journal of surfaces and colloids 2008;24(10):5433-8.
2005: Haim Tsubery; Hertzig Yaakov; Sofia Cohen; Tal Giterman; Ariella Matityahou; Mati Fridkin; Itzhak Ofek
Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria.
Antimicrobial agents and chemotherapy 2005;49(8):3122-8.
2005: Yoram Shechter; Marina Mironchik; Sara Rubinraut; Ayala Saul; Haim Tsubery; Mati Fridkin
Albumin-insulin conjugate releasing insulin slowly under physiological conditions: a new concept for long-acting insulin.
Bioconjugate chemistry 2005;16(4):913-20.
2005: Yoram Shechter; Haim Tsubery; Marina Mironchik; Menachem Rubinstein; Mati Fridkin
Reversible PEGylation of peptide YY3-36 prolongs its inhibition of food intake in mice.
FEBS letters 2005;579(11):2439-44.
2005: Mati Fridkin; Haim Tsubery; Esther Tzehoval; Ami Vonsover; Laura Biondi; Fernando Filira; Raniero Rocchi
Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy.
Journal of peptide science : an official publication of the European Peptide Society 2005;11(1):37-44.
2004: Tal Peleg-Shulman; Haim Tsubery; Marina Mironchik; Mati Fridkin; Gideon Schreiber; Yoram Shechter
Reversible PEGylation: a novel technology to release native interferon alpha2 over a prolonged time period.
Journal of medicinal chemistry 2004;47(20):4897-904.
2004: Haim Tsubery; Marina Mironchik; Mati Fridkin; Yoram Shechter
Prolonging the action of protein and peptide drugs by a novel approach of reversible polyethylene glycol modification.
The Journal of biological chemistry 2004;279(37):38118-24.
2003: Marina Katz; Haim Tsubery; Sofiya Kolusheva; Alex Shames; Mati Fridkin; Raz Jelinek
Lipid binding and membrane penetration of polymyxin B derivatives studied in a biomimetic vesicle system.
The Biochemical journal 2003;375(Pt 2):405-13.
2003: Yoram Shechter; Haim Tsubery; Mati Fridkin
Suspensions of pro-drug insulin greatly prolong normoglycemic patterns in diabetic rats.
Biochemical and biophysical research communications 2003;307(2):315-21.
2003: Yoram Shechter; Haim Tsubery; Mati Fridkin
[2-Sulfo-9-fluorenylmethoxycarbonyl]3-exendin-4-a long-acting glucose-lowering prodrug.
Biochemical and biophysical research communications 2003;305(2):386-91.
2002: Haim Tsubery; Itzhak Ofek; Sofia Cohen; Miriam Eisenstein; Mati Fridkin
Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization.
Molecular pharmacology 2002;62(5):1036-42.
2002: Yoram Shechter; Haim Tsubery; Mati Fridkin
N-[(2-Sulfo)-9-fluorenylmethoxycarbonyl](3)-gentamicin C(1) is a long-acting prodrug derivative.
Journal of medicinal chemistry 2002;45(19):4264-70.
2001: Ari Gargir; Itzhak Ofek; David L Hasty; Shiri Meron-Sudai; Haim Tsubery; Yona Keisari; A Nissim
Inhibition of antibody-dependent stimulation of lipoteichoic acid-treated human monocytes and macrophages by polyglycerolphosphate-reactive peptides.
Journal of leukocyte biology 2001;70(4):537-42.
2001: Haim Tsubery; Itzhak Ofek; Sofia Cohen; Mati Fridkin
N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity.
Peptides 2001;22(10):1675-81.
2000: Haim Tsubery; Itzhak Ofek; Sofia Cohen; Mati Fridkin
The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: studies on polymyxin B nonapeptide.
Biochemistry 2000;39(39):11837-44.
2000: Haim Tsubery; Itzhak Ofek; Sofia Cohen; Mati Fridkin
Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria.
Journal of medicinal chemistry 2000;43(16):3085-92.
2000: Haim Tsubery; Itzhak Ofek; Sofia Cohen; Mati Fridkin
Structure activity relationship study of polymyxin B nonapeptide.
Advances in experimental medicine and biology 2000;479():219-22.